Page 222 - 2021_06-Haematologica-web

N. Oishi et al.
26. Li G, Feng G, Gentil-Perret A, Genin C,
Tostain J. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. J Urol. 2008;180(2):510-513; discussion 513-514.
27. Di Napoli A, De Cecco L, Piccaluga PP, et al. Transcriptional analysis distinguishes breast implant-associated anaplastic large cell lym- phoma from other peripheral T-cell lym- phomas. Mod Pathol. 2019;32(2):216-230.
28. Nasu K, Yamaguchi K, Takanashi T, et al. Crucial role of carbonic anhydrase IX in tumorigenicity of xenotransplanted adult T- cell leukemia-derived cells. Cancer Sci. 2017;108(3):435-443.
29. Higgins DF, Kimura K, Iwano M, Haase VH. Hypoxia-inducible factor signaling in the development of tissue fibrosis. Cell Cycle. 2008;7(9):1128-1132.
30. Lokmic Z, Musyoka J, Hewitson TD, Darby IA. Hypoxia and hypoxia signaling in tissue repair and fibrosis. Int Rev Cell Mol Biol. 2012;296(139-185.
31. de Araujo MF, Etchebehere RM, de Melo MLR, et al. Analysis of CD15, CD57 and HIF-1alpha in biopsies of patients with peri- implantitis. Pathol Res Pract. 2017;213(9): 1097-1101.
32. Rommelt C, Munsch T, Drynda A, Lessmann V, Lohmann CH, Bertrand J. Periprosthetic hypoxia as consequence of TRPM7 mediated cobalt influx in osteoblasts. J Biomed Mater Res B Appl Biomater. 2019;107(6):1806-1813.
33. Kim CH, Kim DH, Oh SH, Song SY. Human embryonic stem cell-derived endothelial precursor cell conditioned medium reduces the thickness of the capsule around silicone implants in rats. Ann Plast Surg. 2015;75(3): 348-352.
34. Mediani L, Gibellini F, Bertacchini J, et al.
Reversal of the glycolytic phenotype of pri- mary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling. Oncotarget. 2016;7(5):5521-5537.
35. Shrestha P, Davis DA, Veeranna RP, Carey RF, Viollet C, Yarchoan R. Hypoxia- inducible factor-1 alpha as a therapeutic tar- get for primary effusion lymphoma. PLoS Pathog. 2017;13(9):e1006628.
36. Brennan DJ, Jirstrom K, Kronblad A, et al. CA IX is an independent prognostic marker in premenopausal breast cancer patients with one to three positive lymph nodes and a putative marker of radiation resistance. Clin Cancer Res. 2006;12(21):6421-6431.
37. Hussain SA, Ganesan R, Reynolds G, et al. Hypoxia-regulated carbonic anhydrase IX expression is associated with poor survival in patients with invasive breast cancer. Br J Cancer. 2007;96(1):104-109.
38. Kon-no H, Ishii G, Nagai K, et al. Carbonic anhydrase IX expression is associated with tumor progression and a poor prognosis of lung adenocarcinoma. Lung Cancer. 2006;54(3):409-418.
39. Lee SH, McIntyre D, Honess D, et al. Carbonic anhydrase IX is a pH-stat that sets an acidic tumour extracellular pH in vivo. Br J Cancer. 2018;119(5):622-630.
40. Svastova E, Witarski W, Csaderova L, et al. Carbonic anhydrase IX interacts with bicar- bonate transporters in lamellipodia and increases cell migration via its catalytic domain. J Biol Chem. 2012;287(5):3392- 3402.
41. Chiche J, Ilc K, Brahimi-Horn MC, Pouyssegur J. Membrane-bound carbonic anhydrases are key pH regulators controlling tumor growth and cell migration. Adv Enzyme Regul. 2010;50(1):20-33.
42. Chiche J, Ilc K, Laferriere J, et al. Hypoxia- inducible carbonic anhydrase IX and XII promote tumor cell growth by counteract- ing acidosis through the regulation of the intracellular pH. Cancer Res. 2009;69(1): 358-368.
43. Lou Y, McDonald PC, Oloumi A, et al. Targeting tumor hypoxia: suppression of breast tumor growth and metastasis by novel carbonic anhydrase IX inhibitors. Cancer Res. 2011;71(9):3364-3376.
44.Sansone P, Piazzi G, Paterini P, et al. Cyclooxygenase-2/carbonic anhydrase-IX up-regulation promotes invasive potential and hypoxia survival in colorectal cancer cells. J Cell Mol Med. 2009;13(9B):3876- 3887.
45. Kuroda N, Tanaka A, Ohe C, Nagashima Y. Recent advances of immunohistochemistry for diagnosis of renal tumors. Pathol Int. 2013;63(8):381-390.
46. Gabriel SE, Woods JE, O'Fallon WM, Beard CM, Kurland LT, Melton LJ 3rd. Complications leading to surgery after breast implantation. N Engl J Med. 1997;336(10):677-682.
47. Spear SL, Rottman SJ, Glicksman C, Brown M, Al-Attar A. Late seromas after breast implants: theory and practice. Plast Reconstr Surg. 2012;130(2):423-435.
48. Hanson SE, Hassid VJ, Branch-Brooks C, et al. Validation of a CD30 enzyme-linked immunosorbant assay for the rapid detec- tion of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2019;40(2):149-153.
49. Clemens MW, Horwitz SM. NCCN consen- sus guidelines for the diagnosis and manage- ment of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2017;37(3):285-289.
1724
haematologica | 2021; 106(6)